-
Yesavage fairytale carries Blue Jays to World Series brink
-
Bank of Japan keeps interest rates unchanged
-
Impoverished Filipinos forge a life among the tombstones
-
Jokic posts fourth straight triple-double as Nuggets rout Pelicans
-
UN calls for end to Sudan siege after mass hospital killings
-
Teenage Australian cricketer dies after being hit by ball
-
As Russia advances on Kupiansk, Ukrainians fear second occupation
-
Trade truce in balance as Trump meets 'tough negotiator' Xi
-
China to send youngest astronaut, mice on space mission this week
-
Yesavage gem carries Blue Jays to brink of World Series as Dodgers downed
-
With inflation under control, ECB to hold rates steady again
-
Asia stocks muted with all eyes on Trump-Xi meeting
-
Personal tipping points: Four people share their climate journeys
-
Moto3 rider Dettwiler 'no longer critical' after crash: family
-
US economy in the dark as government shutdown cuts off crucial data
-
Trump orders nuclear testing resumption ahead of Xi talks
-
'Utter madness': NZ farmers agree dairy sale to French group
-
Samsung posts 32% profit rise on-year in third quarter
-
30 years after cliffhanger vote, Quebec separatists voice hope for independence
-
Taxes, labor laws, pensions: what Milei wants to do next
-
South Sudan's blind football team dreams of Paralympic glory
-
US says 4 killed in new strike on alleged Pacific drug boat
-
What we do and don't know about Rio's deadly police raid
-
'They slit my son's throat' says mother of teen killed in Rio police raid
-
Arteta hails 'special' Dowman after 15-year-old makes historic Arsenal start
-
Google parent Alphabet posts first $100 bn quarter as AI fuels growth
-
Underwater 'human habitat' aims to allow researchers to make weeklong dives
-
Maresca slams Delap for 'stupid' red card in Chelsea win at Wolves
-
'Non-interventionist' Trump flexes muscles in Latin America
-
Slot defends League Cup selection despite not meeting 'Liverpool standards'
-
'Poor' PSG retain Ligue 1 lead despite stalemate and Doue injury
-
Liverpool crisis mounts after League Cup exit against Palace
-
Kane scores twice as Bayern set European wins record
-
Radio Free Asia suspends operations after Trump cuts and shutdown
-
Meta shares sink as $16 bn US tax charge tanks profit
-
Dollar rises after Fed chair says December rate cut not a given
-
Google parent Alphabet posts first $100 bn quarter as AI drives growth
-
Rob Jetten: ex-athlete setting the pace in Dutch politics
-
Juve bounce back after Tudor sacking as Roma keep pace with leaders Napoli
-
Favorite Sovereignty scratched from Breeders' Cup Classic after fever
-
Doue injured as PSG held at Lorient in Ligue 1
-
Leverkusen win late in German Cup, Stuttgart progress
-
Jihadist fuel blockade makes life a struggle in Mali's capital
-
Uber plans San Francisco robotaxis in Waymo challenge
-
Paramilitary chief vows united Sudan as his forces are accused of mass killings
-
Trump, Xi to meet seeking truce in damaging trade war
-
Divided US Fed backs second quarter-point rate cut of 2025
-
'Amazing' feeling for Rees-Zammit on Wales return after NFL adventure
-
'Cruel' police raids help, not hinder, Rio's criminal gangs: expert
-
S. African president eyes better US tariff deal 'soon'
Trump announces drug prices cut with swipe at Europe
US President Donald Trump said Monday he would slash drug prices so that they match costs abroad, accusing the "brutal" European Union in particular of forcing pharmaceutical firms to lower prices on its turf.
Trump claimed as he signed the executive order at the White House that drug prices should fall by at least 59 percent -- and in some cases as high as 80 or 90 percent.
Under the plan, Trump aims to institute a "Most Favored Nation" policy that pins the cost of drugs sold in the United States to the lowest price paid by other countries for the same drug.
"Whoever is paying the lowest price, that's the price that we're going to get," Trump said.
The US president's plan will count mainly on the goodwill of pharmaceutical companies to negotiate their prices and could face legal challenges, as did a similar proposal Trump pushed during his first term.
Trump said American consumers had been treated like "suckers" and cited in particular the costs of the obesity-reducing drug Ozempic, which he said were vastly higher in Europe.
He blasted the European Union nation in particular over drug prices, alleging that the 27-nation bloc forced pharmaceutical firms to lower their costs on their territory.
"It was really the countries that forced Big Pharma to do things that, frankly, I'm not sure they really felt comfortable doing, but they've gotten away with it," Trump said.
"The European Union has been brutal, brutal. And the drug companies actually told me stories it was just brutal, how they forced them."
- 'Powerful lobby' -
Trump said he would also order an investigation into countries that "extort" drug companies by "blocking their products" unless they accepted low prices.
But Trump added that he was also "doing this against the most powerful lobby in the world -- the drug and pharmaceutical lobby."
Health Secretary Robert Kennedy Jr, who has caused controversy for his skepticism over vaccinations, praised the plan.
"There has never been a president more willing to stand up to the oligarchs than Donald Trump," Kennedy said as he stood next to the billionaire property developer.
Trump had trailed the announcement of the 59 percent cut earlier on Monday.
"DRUG PRICES TO BE CUT BY 59%, PLUS! Gasoline, Energy, Groceries, and all other costs, DOWN. NO INFLATION!!!" Trump posted on his Truth Social platform.
The reduction in prescription drug costs in the United States would, he added in his post, be counterbalanced by higher costs in other countries.
"Most favored nation" status is a World Trade Organization rule that aims to prevent discrimination between a country and its trading partners, levelling the playing field for international trade.
This is not the first time that Trump has attempted to lower US drug prices.
During his first 2017-2021 term in office, he announced a similar proposal to cut US drug prices but his plans failed in the face of strong opposition from the pharmaceutical industry.
Last month, the US president signed an executive order aiming to lower crippling drug prices by giving states more leeway to bargain-hunt abroad and improving the process for price negotiations.
T.Germann--VB